Biomind Labs Announces Pre-IND Meeting Request Granted by FDA for Its New Chemical Entity Triptax™ Targeting Treatment-Resistant Depression - StreetInsider.com

Submitted by Anonymous (not verified) on Tue, 10/11/2022 - 16:39

Biomind Labs Announces Pre-IND Meeting Request Granted by FDA for Its New Chemical Entity Triptax™ Targeting Treatment-Resistant Depression  StreetInsider.com